pyrroles has been researched along with tak 285 in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aertgeerts, K; Banno, H; Habuka, N; Ishikawa, T; Kamiguchi, H; Kamiyama, K; Kawakita, Y; Miki, H; Nakayama, A; Ohta, Y; Oorui, M; Seto, M; Sogabe, S; Tamura, T; Tanaka, T; Taniguchi, T; Yano, J | 1 |
| Banno, H; Habuka, N; Ishikawa, T; Iwata, H; Kamiguchi, H; Kawakita, Y; Miki, H; Nakayama, A; Ohashi, T; Ohta, Y; Sogabe, S; Tamura, T; Tanaka, T; Yusa, T | 1 |
2 other study(ies) available for pyrroles and tak 285
| Article | Year |
|---|---|
Design and synthesis of novel human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors bearing a pyrrolo[3,2-d]pyrimidine scaffold.
Topics: Adenosine Triphosphate; Animals; Antineoplastic Agents; Binding Sites; Biological Availability; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Crystallography, X-Ray; Drug Screening Assays, Antitumor; ErbB Receptors; Female; Humans; Hydroxybutyrates; Mice; Mice, Inbred BALB C; Models, Molecular; Neoplasm Transplantation; Protein Conformation; Pyrimidines; Pyrroles; Rats; Receptor, ErbB-2; Structure-Activity Relationship; Transplantation, Heterologous | 2011 |
Design and synthesis of pyrrolo[3,2-d]pyrimidine human epidermal growth factor receptor 2 (HER2)/epidermal growth factor receptor (EGFR) dual inhibitors: exploration of novel back-pocket binders.
Topics: Animals; Biological Availability; Bridged Bicyclo Compounds, Heterocyclic; Drug Design; Enzyme Inhibitors; ErbB Receptors; Female; Humans; Hydroxybutyrates; Mice; Protein-Tyrosine Kinases; Pyrimidines; Pyrroles; Receptor, ErbB-2; Structure-Activity Relationship; Xenograft Model Antitumor Assays | 2012 |